Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 9, 2006, Pages 946-952

  Kolb, Christof ^a,b   Deisenhofer, Isabel ^a   Schmieder, Sebastian ^a   Barthel, Petra ^a   Zrenner, Bernhard ^a   Karch, Martin R ^a   Schmitt, Claus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arrhythmogenic morbidity; Dual chamber implantable cardioverter defibrillator; Long term follow up; Mortality; Right ventricular pacing

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARRHYTHMOGENESIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DEMOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART PACING; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SINUS NODE DISEASE; TREATMENT INDICATION;

ARRHYTHMIA; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT FAILURE ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33748696985     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00467.x     Document Type: Article

References (27)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324.
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940.
3. The Antiarrhythmics Versus Implantable Defibrillator (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resucitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden cardiac death in patients with coronary artery diease: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890.
5. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
6. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resucitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754.
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
8. Gregoratos C, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hiatky MA, Kerber RE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmic devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Commetee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 2002;40:1703-1719.
9. Hauer RN, Aliot E, Block M, Capucci A, L̈uderitz B, Santini M, Vardas PE, et al. Working group on arrhythmias and working group on cardiac pacing: Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Eur Heart J 2001; 22:1074-1081.
10. Lavergne T, Daubert JC, Chauvin M, Dolla E, Kacet S, Leenhardt A, Mabo f, et al. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. Pacing Clin Electrophysiol 1997; 20:182-188.
11. Calkins H, Brinker J, Veltri EP, Guarnieri T, Levine JH. Clinical interactions between pacemakers and automatic implantable cardioverter- defibrillators. J Am Coll Cardiol 1990; 16:666-673.
12. Mattke S, Markewitz A, Muller D, Grunewald A, Fiek M, Schmockel M, Hoffmann E, et al. The combined transvenous implantation of cardioverter defibrillators and permanent pacemakers. Pacing Clin Electrophysiol 1997; 20:2775-2782.
13. Glikson M, Trusty JM, Grice SK, Hayes DL, Hammill SC, Stanton MS. A stepwise testing protocol for modern implantable cardioverter-defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions. Am J Cardiol 1999; 83:360-366.
14. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch MR, Schmieder S, Zrenner B, et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001; 12:134-142.
15. Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004; 44:2362-2367.
16. B̈ansch D, Steffgen F, Gr̈onefeld G, Wolpert C, B̈ocker D, Mletzko RU, Scḧois W, et al. The 1 + 1 trial. A prospective trial of a dual-versus single-chamber implantable defibrillator in patients with slow ventricular tachycardia. Circulation 2004; 110:1022-1029.
17. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288:3115-3123.
18. Nielsen JC, Mortensen PT, Pedersen AK. Long-term follow-up of patients treated with implantable cardioverter defibrillators in a Danish center. Occurrence of ICD therapy and patient survivors. Scand Cardiovasc J 1997; 31:151-6.
19. Narasimhan C, Dhala A, Axtell K, Anderson AJ, Sra J, Deshpande S, Jazayeri MR, et al. Comparison of outcome of implantable cardioverter defibrillator implantation in patients with severe versus moderately severe left ventricular dysfunction secondary to atherosclerothic coronary artery disease. Am J Cardiol 1997; 15:1305-1308.
20. Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone. Eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004; 110:112-116.
21. Glikson M, Lipchenca I, Viskin S, Ballman KV, Trusty JM, Gurevitz OT, Luria DM, et al. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia. J Cardiovasc Electrophysiol 2004; 15:658-664.
22. Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: Echocardiographic and clinical outcome. J Am Coll Cardiol 2003; 42:614-623.
23. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854-1862.
24. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107:2932-2937.
25. Martinez Sanchez J, Garcia Alberol A, Almendral Garrote J, Casellanos E, Perez Castellanos N, Ortiz Paton M, Sanchez Munoz JJ, et al. Ventricular arrhythmias induced by appropriate antibradycardia pacing in patients with implantable defibrillators. Rev Esp Cardiol 2001; 54:845-850.
26. Himmrich E, Przibille O, Zellerhoff C, Liebrich A, Rosocha S, Andreas K, Nebeling D, et al. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators. Circulation 2003; 108:192-197.
27. Proclemer A, Della Bella P, Facchin D, Fattore L, Carbucicchio C, Tondo C, Lunati M, et al. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: A retrospective analysis in the single-chamber defibrillator era. Europace 2001; 3:132-135.